Albuminuria in Patients with Morbid Obesity and the Effect of Weight Loss Following Bariatric Surgery.
Albuminuria
Bariatric surgery
Morbid obesity
Weight loss
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
27
6
2019
medline:
25
6
2020
entrez:
27
6
2019
Statut:
ppublish
Résumé
Patients with morbid obesity are at an increased risk for cardiovascular and renal complications, which are not only linked to traditional cardiovascular risk factors. Thus, we evaluated (a) the prevalence of albuminuria in non-diabetic and diabetic morbidly obese patients and (b) the effect of weight loss following bariatric surgery. We included 1307 patients (77% women, mean age 40 ± 12 years, BMI 45.6 ± 6.6 kg/m In the cross-sectional study, the prevalence of microalbuminuria was 16.0% (n = 209), of macroalbuminuria 3.1% (n = 41). The chi-square for the association of albuminuria and diabetes was 31.937 (p < 0.001). Of all patients with albuminuria, 42.0% exhibited normal glucose tolerance. In a multivariate regression analysis, systolic blood pressure (beta = 0.236; p < 0.001), log fasting insulin (beta = 0.309; p < 0.001) and log 2-h postprandial insulin (beta = - 0.173; p = 0.033) were predictive risk factors for albuminuria. Longitudinally, albumin excretion decreased significantly from 11.1 (6.4, 18.4 mg/24 h) to 7.8 mg/24 h (4.9, 13.0 mg/24 h; p < 0.001). In the group with albuminuria preoperatively, albumin excretion decreased from 65.7 (38.2, 147.1 mg/24 h) to 13.5 mg/24 h (8.4, 36.8 mg/24 h; p < 0.001). After adjusting for age, sex and baseline albuminuria, patients with lower creatinine clearance showed a smaller decrease of albuminuria (beta = 0.117; p = 0.021). A substantial portion of patients with morbid obesity exhibits microalbuminuria, nearly half of those present with normal glucose tolerance. After weight loss, we found a significant decrease of albuminuria, potentially indicating or even contributing to the known reduction of cardiovascular mortality after bariatric surgery.
Sections du résumé
BACKGROUND AND OBJECTIVES
Patients with morbid obesity are at an increased risk for cardiovascular and renal complications, which are not only linked to traditional cardiovascular risk factors. Thus, we evaluated (a) the prevalence of albuminuria in non-diabetic and diabetic morbidly obese patients and (b) the effect of weight loss following bariatric surgery.
MATERIAL AND METHODS
We included 1307 patients (77% women, mean age 40 ± 12 years, BMI 45.6 ± 6.6 kg/m
RESULTS
In the cross-sectional study, the prevalence of microalbuminuria was 16.0% (n = 209), of macroalbuminuria 3.1% (n = 41). The chi-square for the association of albuminuria and diabetes was 31.937 (p < 0.001). Of all patients with albuminuria, 42.0% exhibited normal glucose tolerance. In a multivariate regression analysis, systolic blood pressure (beta = 0.236; p < 0.001), log fasting insulin (beta = 0.309; p < 0.001) and log 2-h postprandial insulin (beta = - 0.173; p = 0.033) were predictive risk factors for albuminuria. Longitudinally, albumin excretion decreased significantly from 11.1 (6.4, 18.4 mg/24 h) to 7.8 mg/24 h (4.9, 13.0 mg/24 h; p < 0.001). In the group with albuminuria preoperatively, albumin excretion decreased from 65.7 (38.2, 147.1 mg/24 h) to 13.5 mg/24 h (8.4, 36.8 mg/24 h; p < 0.001). After adjusting for age, sex and baseline albuminuria, patients with lower creatinine clearance showed a smaller decrease of albuminuria (beta = 0.117; p = 0.021).
CONCLUSION
A substantial portion of patients with morbid obesity exhibits microalbuminuria, nearly half of those present with normal glucose tolerance. After weight loss, we found a significant decrease of albuminuria, potentially indicating or even contributing to the known reduction of cardiovascular mortality after bariatric surgery.
Identifiants
pubmed: 31240536
doi: 10.1007/s11695-019-04036-7
pii: 10.1007/s11695-019-04036-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3581-3588Références
Kidney Int. 2016 Jul;90(1):164-71
pubmed: 27181999
J Hypertens. 2016 Mar;34(3):506-12; discussion 512
pubmed: 26820477
Kidney Int. 2017 May;91(5):1224-1235
pubmed: 28187985
Ann Intern Med. 2006 Jan 3;144(1):21-8
pubmed: 16389251
Kidney Int. 2001 Apr;59(4):1498-509
pubmed: 11260414
Int J Obes (Lond). 2015 Jan;39(1):169-75
pubmed: 24798033
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Endocrinol Nutr. 2015 Mar;62(3):138-43
pubmed: 25637364
Am J Med. 1988 Jun;84(6):1053-60
pubmed: 3376975
Obes Surg. 2012 Mar;22(3):375-80
pubmed: 21590347
J Am Soc Nephrol. 2006 Aug;17(8):2100-5
pubmed: 16825327
J Am Heart Assoc. 2016 Sep 13;5(9):
pubmed: 27625343
Obes Facts. 2015;8(3):188-99
pubmed: 25968610
N Engl J Med. 2017 Feb 16;376(7):641-651
pubmed: 28199805
Eur J Endocrinol. 2010 Nov;163(5):735-45
pubmed: 20798226
J Am Soc Nephrol. 2003 Jun;14(6):1480-6
pubmed: 12761248
N Engl J Med. 2007 Jan 18;356(3):213-5
pubmed: 17229948
Scand J Urol Nephrol. 2003;37(2):151-8
pubmed: 12745725
N Engl J Med. 2007 Aug 23;357(8):753-61
pubmed: 17715409
Nat Rev Nephrol. 2017 Mar;13(3):181-190
pubmed: 28090083
Surg Endosc. 2013 Jun;27(6):2046-51
pubmed: 23292561
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
Kidney Int. 2008 Apr;73(8):947-55
pubmed: 18216780
Obes Surg. 2010 Mar;20(3):308-15
pubmed: 20217955
Curr Diab Rep. 2007 Dec;7(6):449-53
pubmed: 18255009
Surg Obes Relat Dis. 2013 Jan-Feb;9(1):7-14
pubmed: 23211651
J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S213-7
pubmed: 17130264
Surg Obes Relat Dis. 2009 Jan-Feb;5(1):20-6
pubmed: 18951068
Circulation. 2005 Aug 16;112(7):969-75
pubmed: 16087792
Am J Kidney Dis. 2005 Jan;45(1):176-88
pubmed: 15696458
Clin Nephrol. 2008 Sep;70(3):194-202
pubmed: 18793560
Korean J Fam Med. 2016 Jan;37(1):57-63
pubmed: 26885324